.FDA rejects experimental MDMA-assisted therapy for post-traumatic stress disorder NBC NewsF.D.A. Downtrends to Permit MDMA Therapy, Looking For Even More Research The New York TimesFDA Denies Ecstasy-Based Drug The Stock market JournalFDA refuses to permit novel MDMA treatment to treat post-traumatic stress disorder, along with ask for even more trial records CNNFDA rejects first experimental to manage post-traumatic stress disorder, requiring additional research study The Washington Article.